NONSTEMI: Superiority of early angioplasty in non-ST elevation myocardial infarction

The European guidelines recommend revascularization within 24 hours in high-risk patients with No ST segment elevation myocardial infarction. It is unclear whether these patients would benefit from an immediate strategy. This randomized, open, and controlled study included 250 patients with suspected Non ST segment elevation myocardial infarction.

Patients were randomized to early coronary angiography or conventional therapy with coronary angiography within 72 hours. In the conventional therapy group 5% of patients had reinfarction while waiting for coronary angiography and longer hospital stay.

Conclusion

Early coronary angiography in patients with suspected Non ST segment elevation myocardial infarction may improve outcomes and reduce the length of stay.

14_carsten_stengaard
Carsten Stengaard
2015-05-20

Original title: Acute versus subacute angioplasty in patients with non-ST-elevation myocardial infarction – NONSTEMI Trial.

More articles by this author

TOTAL stroke: increased risk of stroke with thromboaspiration

There are many doubts about the benefit of manual thromboaspiration, not only in terms of improvement of the clinical end point but also the...

PARTNER II: Less oversizing to reduce paravalvular failure with the new generation of SAPIEN 3

The new generation SAPIEN 3 valve was designed to reduce paravalvular aortic regurgitation. The objective of this work was to evaluate the influence of...

IN.PACT Global Study: Pharmacological balloon in long lesions of the Superficial Femoral Artery (SFA)

Long lesions (≥ 15 cm), total occlusions, and in-stent restenosis represent a unique treatment challenge in peripheral vascular disease. IN.PACT Global study is a...

Angiographic TOTAL: Sub angiography studio of TOTAL

Myocardial blush is a predictor of mortality after primary angioplasty. Small studies showed a degree of improvement blush with manual thromboaspiration. The present work...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...